29 trends tracked about this subject — the full history, oldest to newest below.
A study of nearly 500,000 people is prompting renewed attention to whether everyday tea drinking supports heart and vascular health.
Two late-stage heart-disease medicines have failed to deliver expected cardiovascular benefits despite promising biomarker improvements, raising questions about how drug developers measure success.
Recent scientific findings indicate that consuming tea can strengthen the heart, though specific conditions govern these benefits.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent medical reviews and reports link testosterone therapy for menopausal women to cognitive insignificance and increased cardiovascular risks.
Recent coverage examines whether weekend lie-ins and irregular sleep schedules increase the risk of heart failure and stroke.
Recent scientific findings reveal that physical activity does more than strengthen the cardiovascular system—it rewires it.
Leading medical societies released a new shared framework and guidelines focused on the phases of women and girls heart health.
New research suggests that regular tea consumption may lower vascular disease risk, though preparation methods like temperature play a critical role.
Recent studies reveal that deep learning models can use ECG data from sleep studies to predict long-term cardiovascular risks.
Recent reports indicate that heart failure rates are rising among adults under sixty-five, signaling a growing health crisis.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
12 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent coverage examines a newly issued warning regarding the health risks of leaving bedroom lights on overnight.
New research suggests that sleeping with lights on, even low-level illumination, may lead to heart dysfunction and structural changes to the heart.
Novo Nordisk has halted two clinical trials for Ziltivekimab, an experimental cardiovascular drug designed to reduce inflammation.
Novo Nordisk has terminated two additional phase 3 trials of its cardiovascular drug ziltivekimab due to futility, impacting its growth strategy.
Novartis and Ionis face setbacks as a high-stakes Phase 3 trial for an Lp(a) cardiovascular drug fails to meet its primary goals.
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Research suggests the popular zero-calorie sweetener Xylitol may be linked to a significantly higher risk of heart attacks and strokes.
Recent reporting across multiple health and news outlets details a newly highlighted cardiovascular risk tied to the artificial sweetener xylitol.
New research suggests the popular sugar substitute xylitol is associated with a 57% higher risk of heart attack, stroke, and death.
Recent studies link the shingles vaccine to significant reductions in dementia and cardiovascular disease risks.
Recent coverage highlights how heart backup blood vessels grow from capillaries rather than existing arteries.
Recent medical coverage examines the potential role of increased potassium intake as a critical factor in the management and control of hypertension.
Pharmaceutical giant Novo Nordisk faces a significant setback following the failure of a late-stage cardiovascular drug trial.
New guidance from the American Heart Association suggests that up to five cups of coffee per day may be safe or beneficial for most adults.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
New research suggests a combination of specific vegetables and chewing gum may impact blood pressure levels.